JPH05307039A - Antibody sensing method - Google Patents

Antibody sensing method

Info

Publication number
JPH05307039A
JPH05307039A JP25567591A JP25567591A JPH05307039A JP H05307039 A JPH05307039 A JP H05307039A JP 25567591 A JP25567591 A JP 25567591A JP 25567591 A JP25567591 A JP 25567591A JP H05307039 A JPH05307039 A JP H05307039A
Authority
JP
Japan
Prior art keywords
processing
sample
antibody
priority
time
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP25567591A
Other languages
Japanese (ja)
Inventor
Akira Tanaka
亮 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
Sumitomo Electric Industries Ltd
Original Assignee
Research Development Corp of Japan
Sumitomo Electric Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Development Corp of Japan, Sumitomo Electric Industries Ltd filed Critical Research Development Corp of Japan
Priority to JP25567591A priority Critical patent/JPH05307039A/en
Publication of JPH05307039A publication Critical patent/JPH05307039A/en
Pending legal-status Critical Current

Links

Landscapes

  • Automatic Analysis And Handling Materials Therefor (AREA)

Abstract

PURPOSE:To establish effective sensing of antibody by performing processing of the other bodies which has high order of priority and is capable of being processed in the wait time after a elapse of the processing time at each processing stage of a body to be inspected. CONSTITUTION:The processing procedures for sensing are set at each processing stage together with the processing time necessary and the wait time, and the order of priority of the sensing process is set between the bodies to be inspected A, B, C. For example, the bodies A1-3, B1-3, C1-3 are selected according to the set orders of priority A>B>C and time of waiting (t), and the sensing process is started with the body, A1, which has the highest order of priority. After elapse of the processing time at this processing stage, the processing is made in the time of waiting Alt, wherein that of the other bodies B, C at the processing stage capable of performing processing with the wait time being zero or having gone, which has high order of priority, i.e., the body B1, is subjected to this processing.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、抗体自動検出装置を用
いた抗体検出法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an antibody detection method using an automatic antibody detection device.

【0002】[0002]

【従来の技術】従来より抗体検出法として、例えば、放
射線免疫測定法(ラジオイムノアッセイ:RIA法)や
酵素免疫測定法(エンザイムイムノアッセイ:ELIS
A法)などが知られている。これらのイムノアッセイに
おいては、抗原抗体反応の高い特異性と検出感度を利用
して、抗体または抗原を同定、定量している。
2. Description of the Related Art Conventional antibody detection methods include, for example, radioimmunoassay (radioimmunoassay: RIA method) and enzyme immunoassay (enzyme immunoassay: ELIS).
A method) etc. are known. In these immunoassays, the antibody or antigen is identified and quantified by utilizing the high specificity and detection sensitivity of the antigen-antibody reaction.

【0003】RIA法は、第2抗体を放射性物質で標識
するため、被爆に対する安全対策と特別の施設を必要と
し、しかも標識化抗体の保存安定性が低いので、現在で
は、主としてELISA法が用いられている。
The RIA method requires a safety measure against exposure to radiation and a special facility because the secondary antibody is labeled with a radioactive substance, and the storage stability of the labeled antibody is low. Therefore, at present, the ELISA method is mainly used. Has been.

【0004】ELISA法の中にも多くの種類がある
が、例えば、モノクローナル抗体の検出・定量に用いら
れる固相ELISAを例にとると、(1)予め固相に固
定化した抗原に測定対象となるモノクローナル抗体を反
応させ、ついで酵素標識化した第2抗体を反応させる間
接法、(2)補足抗体を固相に固定し、その後多価抗原
を加えて結合させた上に、測定対象となるモノクローナ
ル抗体を反応させ、ついで酵素標識化した第2抗体を反
応させるサンドイッチ法、(3)固相化抗原と遊離抗原
間で競合を行なったり、あるいは固相化抗原とハプテン
物質間で競合を行なう競合ELISA法(競合間接法、
競合サンドイッチ法)などがある。
There are many kinds of ELISA methods. For example, taking solid-phase ELISA used for detection and quantification of monoclonal antibody as an example, (1) an object to be measured is an antigen which is immobilized on a solid phase in advance. Indirect method in which a monoclonal antibody to be reacted is reacted, and then an enzyme-labeled second antibody is reacted, (2) The complementary antibody is immobilized on a solid phase, and then a polyvalent antigen is added and allowed to bind to the measurement target. Sandwich method in which the following monoclonal antibody is reacted, and then the enzyme-labeled second antibody is reacted, (3) competition between immobilized antigen and free antigen, or competition between immobilized antigen and hapten substance Competitive ELISA method (Competitive indirect method,
Competitive sandwich method) etc.

【0005】このようにELISA法には、多くの種類
があるが、基本的には、検出処理開始から終了に至るま
での複数の処理段階を含む処理手順からなり、一連の処
理を逐次(シーケンシャルに)行なう方法である。そし
て、各処理段階では、一定の処理を行なった後、一定時
間(待ち時間)放置することが必要である。
As described above, although there are many kinds of ELISA methods, they basically consist of a processing procedure including a plurality of processing steps from the start to the end of the detection processing, and a series of processing is sequentially (sequentially). This is how to do it. Then, in each processing stage, it is necessary to perform a certain process and then leave it for a certain time (waiting time).

【0006】例えば、前記サンドイッチ法を例に取る
と、通常、図1に示すような処理手順により抗体検出処
理が行なわれている。 (a)先ず、固相支持体(例えば、96ウエルのポリス
チレンプレート)1の各アッセイ穴に1種の特異抗体2
を含む液を分注し、一定時間インキュベーションして固
相表面に該抗体を吸着させた後、洗浄する。
[0006] For example, taking the sandwich method as an example, the antibody detection process is usually carried out by the procedure shown in FIG. (A) First, one type of specific antibody 2 is placed in each assay hole of a solid support (for example, a 96-well polystyrene plate) 1.
Is dispensed and incubated for a certain period of time to adsorb the antibody on the surface of the solid phase, followed by washing.

【0007】(b)固相支持体上の未吸着の部位をブロ
ック(非特異的な反応が生じるのを防止)するために、
特異抗体を固定化したプレートの各アッセイ穴に、該抗
体と無関係なタンパク質3を含む液を分注し、一定時間
インキュベーションした後、洗浄する。
(B) In order to block unadsorbed sites on the solid support (prevent nonspecific reaction),
A solution containing protein 3 irrelevant to the antibody is dispensed into each assay hole of the plate on which the specific antibody is immobilized, and the plate is incubated for a certain period of time and then washed.

【0008】(c)各アッセイ穴に、多価抗原4を含む
液を分注し、一定時間インキュベーションして反応させ
た後、洗浄する。 (d)検体として、抗原に特異的な抗体〔前記(a)で
吸着に用いた種と異なる動物種由来の特異抗体〕5を含
む液を分取して、各アッセイ穴に分注し、一定時間イン
キュベーションして反応させた後、洗浄する。
(C) A solution containing polyvalent antigen 4 is dispensed into each assay hole, incubated for a certain period of time to react, and then washed. (D) As a sample, a liquid containing an antibody specific to an antigen [specific antibody derived from an animal species different from the species used for adsorption in (a) above] 5 is collected and dispensed into each assay hole, Incubate for a certain period of time to react, and then wash.

【0009】(e)前記抗原に特異的な抗体が属してい
る抗体クラスに特異性を示し、酵素標識化された第2抗
体〔(d)で用いる抗体の動物種に特異的な抗体:酵素
標識抗イムノグロブリン抗体〕6を含む液を各アッセイ
穴に分注し、一定時間インキュベーションして反応させ
た後、洗浄する。
(E) An enzyme-labeled second antibody showing specificity to the antibody class to which the antibody specific to the above-mentioned antigen belongs [Antibodies specific to the animal species of the antibody used in (d): enzyme A solution containing labeled anti-immunoglobulin antibody] 6 is dispensed into each assay hole, incubated for a certain period of time to react, and then washed.

【0010】(f)酵素基質およびインジケーター7を
含む酵素基質溶液を各アッセイ穴に分注し、一定時間イ
ンキュベーションして反応させる。 (g)分光光度計(ELISAプレート・リーダー)あ
るいは比色計で吸光度を測定し、発色強度で第2抗体を
検出・定量し、抗原に反応した特異抗体の有無や量を検
出する。
(F) An enzyme substrate solution containing the enzyme substrate and the indicator 7 is dispensed into each assay well and incubated for a certain period of time to react. (G) Absorbance is measured with a spectrophotometer (ELISA plate reader) or a colorimeter, and the second antibody is detected and quantified based on the intensity of color development to detect the presence or absence and the amount of the specific antibody that has reacted with the antigen.

【0011】この例に見られるように、抗体検出法は、
検出処理開始(a)から終了(g)に至るまでの逐次的
な複数の処理段階を含む処理手順から構成されており、
各処理段階では、一定の処理を行なった後、通常、イン
キュベーション等のために一定時間放置することが必要
である。この放置時間が待ち時間となっているが、イン
キュベーションまたは反応に長時間を要することが多
い。
As seen in this example, the antibody detection method is
It is composed of a processing procedure including a plurality of sequential processing steps from the detection processing start (a) to the end (g),
In each treatment stage, it is usually necessary to perform a certain treatment and then leave it for a certain period of time for incubation or the like. This waiting time is a waiting time, but incubation or reaction often takes a long time.

【0012】一方、前記のような抗体検出法を自動化し
た抗体検出装置も知られている。具体的には、試薬供給
部、検体供給部、分取分注部、搬送部、測定部、結果出
力部およびこれらの制御部を有する抗体検出装置でる。
ところが、このような従来の自動化装置においても、前
記と同様の一連の処理をシーケンシャルに行なうだけで
あった。
On the other hand, there is also known an antibody detection device that automates the antibody detection method as described above. Specifically, it is an antibody detection device having a reagent supply unit, a sample supply unit, a preparative dispensing unit, a transport unit, a measurement unit, a result output unit, and these control units.
However, even in such a conventional automation device, a series of processes similar to the above is merely performed sequentially.

【0013】そのため、従来の装置では、待ち時間を有
効に活用できないこと、処理手順の異なる検体が混在で
きないこと、処理操作の途中で検体を追加できないこ
と、などの欠点を有していた。
Therefore, the conventional apparatus has drawbacks such that the waiting time cannot be effectively utilized, samples having different processing procedures cannot be mixed, and samples cannot be added during the processing operation.

【0014】[0014]

【発明が解決しようとする課題】本発明の目的は、自動
化された抗体検出装置を用いて抗体を自動的に検出する
方法において、待ち時間を有効に活用して、他の検体の
処理や処理手順の異なる検体の処理、あるいは処理操作
途中で検体の追加が可能な抗体検出法を提供することに
ある。
DISCLOSURE OF THE INVENTION An object of the present invention is to provide a method for automatically detecting an antibody using an automated antibody detection apparatus, by effectively utilizing the waiting time to process or process other samples. It is an object of the present invention to provide an antibody detection method capable of processing a sample having a different procedure or adding a sample during the processing operation.

【0015】本発明者は、前記従来技術の問題点を克服
するために鋭意研究した結果、検体の種類に応じて、予
め一連の処理手順と、各処理段階で必要とする処理時間
および待ち時間を設定し、かつ、検出処理のために受け
付けた各検体間に優先度を設定し、各検体の検出処理を
行なうに当たり、処理する検体を設定された優先度およ
び待ち時間により選択して、ある検体の一処理段階にお
ける処理時間経過後、その待ち時間に、待ち時間を経過
して処理可能な処理段階にある他の検体のうち、優先度
の高い検体の処理を行なうことにより、前記目的を達成
できることを見出し、本発明を完成するに至った。
As a result of earnest studies to overcome the above-mentioned problems of the prior art, the present inventor found that a series of processing procedures and processing time and waiting time required at each processing step were prepared in advance according to the type of sample. Is set, and priorities are set among the samples received for the detection process, and when performing the detection process of each sample, the sample to be processed is selected according to the set priority and waiting time. After the processing time in one processing stage of the sample has passed, during the waiting time, among the other samples in the processing stage that can be processed after the waiting time has passed, by processing the sample with high priority, They have found that they can be achieved, and have completed the present invention.

【0016】[0016]

【課題を解決するための手段】かくして本発明によれ
ば、試薬供給部、検体供給部、分取分注部、搬送部、測
定部、結果出力部およびこれらの制御部を有する抗体検
出装置を用いて抗体を自動的に検出する方法において、 (1)検体(検出対象となる抗体)の種類に応じて、検
出処理開始から終了に至るまでの逐次的な複数の処理段
階を含む処理手順を、各処理段階において必要な処理時
間および待ち時間とともに設定し、かつ、 (2)受け付けた各検体間に検出処理の優先度を設定し
て、
Thus, according to the present invention, there is provided an antibody detection device having a reagent supply section, a sample supply section, a preparative dispensing section, a transfer section, a measurement section, a result output section, and a control section thereof. In the method of automatically detecting an antibody using (1) a treatment procedure including a plurality of treatment steps from the start to the end of the detection treatment depending on the type of the sample (antibody to be detected) , Setting the processing time and waiting time required in each processing stage, and (2) setting the priority of the detection processing among the received samples,

【0017】(3)各検体の検出処理を行なうに当た
り、 処理する検体を設定された優先度および待ち時間によ
り選択して、 優先度の最も高い検体から検出処理を開始し、 ある検体の一処理段階における処理時間経過後、その
待ち時間に、 待ち時間がゼロまたは待ち時間を経過して処理可能な
処理段階にある他の検体のうち、優先度の高い検体の処
理を行なう、 ことを特徴とする抗体検出方法が提供される。
(3) When performing the detection process of each sample, the sample to be processed is selected according to the set priority and waiting time, the detection process is started from the sample with the highest priority, and one sample is processed. After the lapse of the processing time in the stage, during the waiting time, a sample having a high priority is processed among other samples in the processing stage where the waiting time is zero or the waiting time has passed and can be processed. A method for detecting an antibody is provided.

【0018】以下、本発明について詳述する。本発明で
使用する抗体検出装置は、その一構成例を図4のブロッ
ク図として示すように、試薬供給部、検体供給部、分取
分注部、搬送部、測定部、結果出力部およびこれらの制
御部を有している。また、抗体検出装置の一構成例の斜
視図を図5に示す。図5の抗体検出装置は、試薬供給部
52、検体供給部51、分取分注部53、搬送部54、
測定部55、結果出力部57およびこれらの制御部56
を有している。
The present invention will be described in detail below. The antibody detection apparatus used in the present invention has a configuration example shown in the block diagram of FIG. 4, in which a reagent supply section, a sample supply section, a dispensing section, a transfer section, a measurement section, a result output section, and the like. It has a control unit. FIG. 5 is a perspective view of a configuration example of the antibody detection device. The antibody detection device of FIG. 5 includes a reagent supply unit 52, a sample supply unit 51, a dispensing unit 53, a transport unit 54,
Measurement unit 55, result output unit 57 and control unit 56 thereof
have.

【0019】図2は、本発明による抗体検出方法のフロ
ーチャートの一例である。 先ず、検体(検出対象となる抗体)の種類に応じて、
検出処理開始から終了に至るまでの逐次的な複数の処理
段階を含む処理手順を、各処理段階において必要な処理
時間および待ち時間とともに設定し、かつ、受け付けた
各検体間に検出処理の優先度を設定して、制御部に入力
する。
FIG. 2 is an example of a flow chart of the antibody detection method according to the present invention. First, depending on the type of sample (antibody to be detected),
Set the processing procedure including multiple sequential processing steps from the start to the end of the detection processing together with the processing time and waiting time required for each processing step, and set the priority of the detection processing between the received samples. Is set and input to the control unit.

【0020】各検体の検出処理を行なうに当たり、各
検体間の優先度をチェックし、最も優先度の高い検体か
ら検出処理を開始する。 検体追加チェックは、新たな検体が追加されるのかど
うかを判定し、追加されるのならば、その検体につい
て、種類、処理手順、各処理段階での処理時間と待ち時
間、および優先度の入力を受け付ける。 処理中の検体について、処理手順の終了の有無をチェ
ックし、次の処理段階のある場合には、その優先度と待
ち時間をチェックする。
When performing the detection process for each sample, the priority among the samples is checked, and the detection process is started from the sample having the highest priority. The sample addition check determines whether or not a new sample is added, and if it is added, the type, processing procedure, processing time and waiting time at each processing stage, and priority input for that sample. Accept. For the sample being processed, it is checked whether the processing procedure is completed, and if there is the next processing stage, the priority and waiting time are checked.

【0021】優先度および待ち時間チェックでは、現
在装置内にある各検体のうち待ち時間中でないものを選
択して、その次の処理段階を実行することを決定する。
すなわち、ある検体の待ち時間中に、待ち時間がゼロま
たは待ち時間を経過して処理可能な処理段階にある他の
検体のうち、優先度の高い検体の処理を行なう。 以下、すべての検体について、同様のフローにより検
出処理を行なう。 図3は、本発明による抗体検出法の処理の流れを示すタ
イムチャートの一例である。
In the priority and waiting time check, it is decided to select one of the specimens currently in the apparatus which is not in waiting time and execute the next processing step.
That is, during the waiting time of a certain sample, the sample having a high priority is processed among the other samples in the processing stage where the waiting time is zero or the waiting time has elapsed. Hereinafter, the detection process is performed for all the samples according to the same flow. FIG. 3 is an example of a time chart showing a processing flow of the antibody detection method according to the present invention.

【0022】[0022]

【実施例】前記図2と図3を参照しながら、本発明の抗
体検出法の一実施例について説明する。例えば、検体が
A、BおよびCの3種類であって、これらの3種類の検
体について、処理手順、それぞれの処理段階における処
理時間と待ち時間、および優先度を下記のように設定し
た場合について説明する。
EXAMPLE An example of the antibody detection method of the present invention will be described with reference to FIGS. For example, in the case where there are three types of samples, A, B, and C, and the processing procedure, the processing time and waiting time in each processing stage, and the priority for these three types of samples are set as follows. explain.

【0023】(a)検体A、BおよびCの処理手順 A:A1、A2、A3、 B:B1、B2、B3、 C:C1、C2、C3。 ただし、図3中、A1、A2などは、各処理段階での処理
時間をも表わす。
(A) Treatment procedure of specimens A, B and C A: A 1 , A 2 , A 3 , B: B 1 , B 2 , B 3 , C: C 1 , C 2 , C 3 . However, in FIG. 3, A 1 , A 2, etc. also represent the processing time at each processing stage.

【0024】(b)それぞれの処理段階(ステップ)に
ついての待ち時間 A:A1t、A2t、A3t、 B:B1t、B2t、B3t、 C:C1t、C2t、C3t。 (c)優先順位(優先度) A>B>C
(B) Waiting time for each processing step A: A 1 t, A 2 t, A 3 t, B: B 1 t, B 2 t, B 3 t, C: C 1 t , C 2 t, C 3 t. (C) Priority (Priority) A>B> C

【0025】図2の優先度チェックにより、装置は、検
体Aに対し処理A1を実行する。実行終了後、待ち時間
1tだけ待つ。その間、装置は、検体追加チェックを
行ない、優先度および反応待ち時間チェックにより、次
に優先度の高い検体Bの処理B1を実行する。実行終了
後、待ち時間B1tだけ待つ。その間に、検体Aに対し
て待ち時間A1t以上経過したか否かをチェックし、経
過していなければ、検体Cに対し処理C1を実行する。
経過していれば、AとCとの優先度より、検体Aに対し
処理A2を実行する。以下、同様に、各検体の各処理段
階について、優先度と待ち時間をチェックして、優先度
に応じて各処理を実行する。
According to the priority check of FIG. 2, the apparatus executes the process A 1 on the sample A. After the end of execution, wait for waiting time A 1 t. In the meantime, the apparatus performs the sample addition check, and executes the process B 1 of the sample B having the next highest priority by checking the priority and the reaction waiting time. After the end of execution, wait for waiting time B 1 t. In the meantime, it is checked whether the waiting time A 1 t or more has passed for the sample A, and if not, the process C 1 is executed for the sample C.
If the time has passed, the process A 2 is executed for the sample A according to the priority of A and C. Hereinafter, similarly, the priority and the waiting time are checked for each processing stage of each sample, and each processing is executed according to the priority.

【0026】このように、1つの検体に対し、1つの処
理段階が終了する度に、待ち時間と優先度のチェックを
行ない、処理可能な検体を選択し、実行するため、ある
検体の待ち時間中にも他の検体の処理が行なわれ、しか
も同時に異なった処理手順と待ち時間の検体を処理でき
る。
As described above, the waiting time and priority of each sample are checked every time one processing step is completed, and the sample that can be processed is selected and executed. Other samples are processed in the process, and at the same time, samples with different processing procedures and waiting times can be processed.

【0027】さらに、1つの処理が終了するごとに、検
体追加チェックを行ない、検体を追加した場合、同時に
処理手順、各処理段階での処理時間と待ち時間、種類、
および優先順位を設定し、動作途中での新たな追加も可
能である。
Further, when a sample is added every time one process is completed and a sample is added, the processing procedure, the processing time and waiting time at each processing stage, the type,
It is also possible to set priorities and add new ones during the operation.

【0028】[0028]

【発明の効果】本発明によれば、抗体自動検出装置を用
いて抗体検出を行なうに当たり、待ち時間を有効に活用
でき、処理手順の異なる多種の検体が混在でき、処理操
作途中で検体を追加できる点で、生化学、医薬品などの
分野で大量の検体を処理するスクリーニングや研究用に
利用すると効率的である。
EFFECTS OF THE INVENTION According to the present invention, when performing antibody detection using the automatic antibody detection device, the waiting time can be effectively utilized, various samples having different processing procedures can be mixed, and samples can be added during the processing operation. Because of this, it is efficient to use it for screening and research that processes a large amount of samples in fields such as biochemistry and pharmaceuticals.

【図面の簡単な説明】[Brief description of drawings]

【図1】一般的な抗体検出法の処理手順の一例を示す説
明図である。
FIG. 1 is an explanatory diagram showing an example of a processing procedure of a general antibody detection method.

【図2】本発明による抗体検出法の手順の一例を示すフ
ローチャートである。
FIG. 2 is a flowchart showing an example of the procedure of the antibody detection method according to the present invention.

【図3】本発明による抗体検出法の流れの一例を示すタ
イムチャートである。
FIG. 3 is a time chart showing an example of the flow of the antibody detection method according to the present invention.

【図4】本発明で用いる抗体検出装置の一構成例を示す
ブロック図である。
FIG. 4 is a block diagram showing a configuration example of an antibody detection device used in the present invention.

【図5】本発明で用いる抗体検出装置の一構成例を示す
の斜視図である。
FIG. 5 is a perspective view showing a configuration example of an antibody detection device used in the present invention.

【符合の説明】[Explanation of sign]

1 固相支持体 2 特異抗体 3 抗原と無関係なタンパク質 4 多価抗原 5 抗原に特異的な抗体 6 酵素標識抗イムノグロブリン抗体 7 酵素基質およびインジケーター 1 solid support 2 specific antibody 3 protein unrelated to antigen 4 polyvalent antigen 5 antibody specific to antigen 6 enzyme-labeled anti-immunoglobulin antibody 7 enzyme substrate and indicator

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 試薬供給部、検体供給部、分取分注部、
搬送部、測定部、結果出力部およびこれらの制御部を有
する抗体検出装置を用いて抗体を自動的に検出する方法
において、 (1)検体(検出対象となる抗体)の種類に応じて、検
出処理開始から終了に至るまでの逐次的な複数の処理段
階を含む処理手順を、各処理段階において必要な処理時
間および待ち時間とともに設定し、かつ、 (2)受け付けた各検体間に検出処理の優先度を設定し
て、 (3)各検体の検出処理を行なうに当たり、 処理する検体を設定された優先度および待ち時間によ
り選択して、 優先度の最も高い検体から検出処理を開始し、 ある検体の一処理段階における処理時間経過後、その
待ち時間に、 待ち時間がゼロまたは待ち時間を経過して処理可能な
処理段階にある他の検体のうち、優先度の高い検体の処
理を行なう、 ことを特徴とする抗体検出方法。
1. A reagent supply section, a sample supply section, a preparative dispensing section,
In a method for automatically detecting an antibody using an antibody detection device having a transport section, a measurement section, a result output section, and a control section thereof, (1) detection is performed according to the type of sample (antibody to be detected) A processing procedure including a plurality of sequential processing steps from the start to the end of processing is set together with the processing time and waiting time required in each processing step, and (2) detection processing is performed between the received samples. Setting the priority, (3) When performing the detection process for each sample, select the sample to be processed according to the set priority and waiting time, and start the detection process from the sample with the highest priority. After the processing time in one processing stage of the sample has elapsed, during the waiting time, the sample with the higher priority is processed among the other samples in the processing stage where the waiting time is zero or the waiting time has passed. A method for detecting an antibody, comprising:
JP25567591A 1991-09-07 1991-09-07 Antibody sensing method Pending JPH05307039A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP25567591A JPH05307039A (en) 1991-09-07 1991-09-07 Antibody sensing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25567591A JPH05307039A (en) 1991-09-07 1991-09-07 Antibody sensing method

Publications (1)

Publication Number Publication Date
JPH05307039A true JPH05307039A (en) 1993-11-19

Family

ID=17282062

Family Applications (1)

Application Number Title Priority Date Filing Date
JP25567591A Pending JPH05307039A (en) 1991-09-07 1991-09-07 Antibody sensing method

Country Status (1)

Country Link
JP (1) JPH05307039A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07280815A (en) * 1994-04-06 1995-10-27 Hitachi Ltd Automatic specimen processing system
JP2006105913A (en) * 2004-10-08 2006-04-20 Fuji Photo Film Co Ltd Screening system
US8175810B2 (en) 2006-08-04 2012-05-08 Canon Kabushiki Kaisha Sample processing apparatus and sample processing method
WO2015105114A1 (en) * 2014-01-10 2015-07-16 コニカミノルタ株式会社 Immunoassay method and immunoassay system
CN113196065A (en) * 2018-12-19 2021-07-30 株式会社日立高新技术 Automatic analysis device and analysis method
WO2022270044A1 (en) * 2021-06-24 2022-12-29 株式会社日立ハイテク Automated analysis device

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07280815A (en) * 1994-04-06 1995-10-27 Hitachi Ltd Automatic specimen processing system
JP2006105913A (en) * 2004-10-08 2006-04-20 Fuji Photo Film Co Ltd Screening system
JP4549803B2 (en) * 2004-10-08 2010-09-22 富士フイルム株式会社 Screening system
US8175810B2 (en) 2006-08-04 2012-05-08 Canon Kabushiki Kaisha Sample processing apparatus and sample processing method
WO2015105114A1 (en) * 2014-01-10 2015-07-16 コニカミノルタ株式会社 Immunoassay method and immunoassay system
JPWO2015105114A1 (en) * 2014-01-10 2017-03-23 コニカミノルタ株式会社 Immunoassay method and immunoassay system
US10545141B2 (en) 2014-01-10 2020-01-28 Konica Minolta, Inc. Immunoassay method and immunoassay system
CN113196065A (en) * 2018-12-19 2021-07-30 株式会社日立高新技术 Automatic analysis device and analysis method
CN113196065B (en) * 2018-12-19 2023-09-29 株式会社日立高新技术 Automatic analysis device and analysis method
WO2022270044A1 (en) * 2021-06-24 2022-12-29 株式会社日立ハイテク Automated analysis device

Similar Documents

Publication Publication Date Title
US4496654A (en) Detection of HCG with solid phase support having avidin coating
Nemzek et al. Development and optimization of cytokine ELISAs using commercial antibody pairs
Bock The new era of automated immunoassay
US5217905A (en) Device and method for the rapid qualitative and quantitative determination of the presence of a reactive ligand in a fluid
Johannsson Heterogeneous enzyme immunoassay
JPH07151757A (en) Noncompetitive bond assay method
Märtlbauer et al. Immunochemical detection of antibiotics and sulfonamides
EP0207152B1 (en) Solid phase diffusion assay
Tsounidi et al. Rapid and sensitive label-free determination of aflatoxin M1 levels in milk through a White Light Reflectance Spectroscopy immunosensor
Rennard et al. Enzyme linked immunoassay (ELISA) for connective tissue proteins: type I collagen
Liu et al. Validation of a Gyrolab™ assay for quantification of rituximab in human serum
JPH05307039A (en) Antibody sensing method
JP5073507B2 (en) Multiple immunochemical assays on elements
US4966839A (en) Process for the determination of an immunologically bindable analyte
Wu et al. Matrix interference in serum total thyroxin (T4) time-resolved fluorescence immunoassay (TRFIA) and its elimination with the use of streptavidin–biotin separation technique
Law et al. Enzyme-linked immunosorbent assay (ELISA) development and optimisation
Deshpande Assay development, evaluation, and validation
Smith et al. [27] Semiautomation of immunoassays by use of magnetic transfer devices
Yang et al. Development of a novel parallel determination platform: a feasibility study tested on a chemiluminescence device
Wheeler The measurement of LH, FSH, and prolactin
Taimela et al. Third generation time-resolved immunofluorometric TSH assay for automatic immunoassay system evaluated
Winger et al. Enhanced specificity for small molecules in a convenient format which removes a limitation of competitive immunoassay
RODBARD Radioimmunoassays and 2-site immunoradiometric “sandwich” assays: Basic principles
Chaudhari et al. AN OVERVIEW ON ELISAS TECHNIQUES FOR ANALYTE DETECTION TO NEW LEVELS: A REVIEW
Wheeler Assays for LH, FSH, and prolactin